Table 1 Demografic and clinical characteristics at baseline
NGLCD (n = 58) | LFD (n = 52) | |||
|---|---|---|---|---|
Gender | M (n = 26) | F (n = 32) | M (n = 21) | F (n = 31) |
Age (years) | 52.5 ± 7.1 | 55.4 ± 9.7 | 52 ± 8.4 | 54.9 ± 10.1 |
BMI (kg/m2) | 30.6 ± 4.4 | 29.6 ± 2.3* | 30.7 ± 4.2 | 28.5 ± 2.4** |
WC (cm) | 95.6 ± 15.4 | 91.5 ± 12.2 | 98 ± 12.4 | 89.02 ± 9.8 |
Obesity (number, %) | 19 (73.1%) | 24 (75%) | 16 (76.2%) | 22 (71%) |
Hypertriglyceridemia (number, %) | 18 (69.2%) | 15 (46.9%) | 17 (81%) | 17 (54.8%) |
HypoHDL-cholesterolemia (number, %) | 18 (69.2%) | 19 (59.4%) | 17 (81%) | 15 (48.4%) |
Cigarette smoking (number, %) | 10 (38.5%) | 13 (40.6%) | 7 (33.3%) | 11 (35.5%) |
Diabetes (number, %) | 11 (42.3%) | 7 (21.9%) | 9 (42.9%) | 6 (19.4%) |
IGT (number, %) | 1 (3.8%) | 4 (12.5%) | 5 (23.8%) | 2 (6.5%) |
IFG (number, %) | 5 (19.2%) | 2 (6.3%) | 1 (4.8%) | 6 (19.4%) |
Normal glucose tolerance (number, %) | 14 (53.8%) | 21 (65.6%) | 11 (52.4%) | 19 (61.3%) |
Hypertension (number, %) | 15 (57.7%) | 13 (40.6%) | 11 (52.4%) | 19 (61.3%) |
MetS (number, %) | 18 (69.9%) | 18 (56.3%) | 18 (85.7%) | 14 (45.2%)*** |